105 related articles for article (PubMed ID: 23545721)
1. The metabolic profile of mitoxantrone and its relation with mitoxantrone-induced cardiotoxicity.
Rossato LG; Costa VM; de Pinho PG; Arbo MD; de Freitas V; Vilain L; de Lourdes Bastos M; Palmeira C; Remião F
Arch Toxicol; 2013 Oct; 87(10):1809-20. PubMed ID: 23545721
[TBL] [Abstract][Full Text] [Related]
2. Naphthoquinoxaline metabolite of mitoxantrone is less cardiotoxic than the parent compound and it can be a more cardiosafe drug in anticancer therapy.
Reis-Mendes A; Gomes AS; Carvalho RA; Carvalho F; Remião F; Pinto M; Bastos ML; Sousa E; Costa VM
Arch Toxicol; 2017 Apr; 91(4):1871-1890. PubMed ID: 27629428
[TBL] [Abstract][Full Text] [Related]
3. The age factor for mitoxantrone's cardiotoxicity: multiple doses render the adult mouse heart more susceptible to injury.
Dores-Sousa JL; Duarte JA; Seabra V; Bastos Mde L; Carvalho F; Costa VM
Toxicology; 2015 Mar; 329():106-19. PubMed ID: 25582955
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial cumulative damage induced by mitoxantrone: late onset cardiac energetic impairment.
Rossato LG; Costa VM; Dallegrave E; Arbo M; Silva R; Ferreira R; Amado F; Dinis-Oliveira RJ; Duarte JA; de Lourdes Bastos M; Palmeira C; Remião F
Cardiovasc Toxicol; 2014 Mar; 14(1):30-40. PubMed ID: 24096626
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic concentrations of mitoxantrone elicit energetic imbalance in H9c2 cells as an earlier event.
Rossato LG; Costa VM; Vilas-Boas V; de Lourdes Bastos M; Rolo A; Palmeira C; Remião F
Cardiovasc Toxicol; 2013 Dec; 13(4):413-25. PubMed ID: 24046265
[TBL] [Abstract][Full Text] [Related]
6. Subchronic administration of mitoxantrone and the influence of enzyme inhibitors on its induced cardiotoxicity in mice: role of NRF-2/CYP2E1.
Emeka PM; Ibrahim HIM; Alhaider IA; Morsy MA; Mohamed ME
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):7806-7822. PubMed ID: 34982442
[TBL] [Abstract][Full Text] [Related]
7. Autophagy (but not metabolism) is a key event in mitoxantrone-induced cytotoxicity in differentiated AC16 cardiac cells.
Reis-Mendes A; Carvalho F; Remião F; Sousa E; de Lourdes Bastos M; Costa VM
Arch Toxicol; 2023 Jan; 97(1):201-216. PubMed ID: 36216988
[TBL] [Abstract][Full Text] [Related]
8. Cumulative mitoxantrone-induced haematological and hepatic adverse effects in a subchronic in vivo study.
Rossato LG; Costa VM; Dallegrave E; Arbo M; Dinis-Oliveira RJ; Santos-Silva A; Duarte JA; de Lourdes Bastos M; Palmeira C; Remião F
Basic Clin Pharmacol Toxicol; 2014 Mar; 114(3):254-62. PubMed ID: 24119282
[TBL] [Abstract][Full Text] [Related]
9. Mitoxantrone impairs proteasome activity and prompts early energetic and proteomic changes in HL-1 cardiomyocytes at clinically relevant concentrations.
Costa VM; Capela JP; Sousa JR; Eleutério RP; Rodrigues PRS; Dores-Sousa JL; Carvalho RA; Lourdes Bastos M; Duarte JA; Remião F; Almeida MG; Varner KJ; Carvalho F
Arch Toxicol; 2020 Dec; 94(12):4067-4084. PubMed ID: 32894303
[TBL] [Abstract][Full Text] [Related]
10. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P-450-induced cytotoxicity of mitoxantrone by formation of electrophilic intermediates.
Mewes K; Blanz J; Ehninger G; Gebhardt R; Zeller KP
Cancer Res; 1993 Nov; 53(21):5135-42. PubMed ID: 8221649
[TBL] [Abstract][Full Text] [Related]
12. Characterization of experimental mitoxantrone cardiotoxicity and its partial inhibition by ICRF-187 in cultured neonatal rat heart cells.
Shipp NG; Dorr RT; Alberts DS; Dawson BV; Hendrix M
Cancer Res; 1993 Feb; 53(3):550-6. PubMed ID: 8425187
[TBL] [Abstract][Full Text] [Related]
13. Chronic doxorubicin cardiotoxicity modulates cardiac cytochrome P450-mediated arachidonic acid metabolism in rats.
Alsaad AM; Zordoky BN; El-Sherbeni AA; El-Kadi AO
Drug Metab Dispos; 2012 Nov; 40(11):2126-35. PubMed ID: 22867862
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P450 inactivation during reductive metabolism of 1,1-dichloro-2,2,2-trifluoroethane (HCFC-123) by phenobarbital- and pyridine-induced rat liver microsomes.
Ferrara R; Tolando R; King LJ; Manno M
Toxicol Appl Pharmacol; 1997 Apr; 143(2):420-8. PubMed ID: 9144458
[TBL] [Abstract][Full Text] [Related]
15. [Effect of water extract from traditional Chinese medicines Rehmannia glutinosa, Scrophularia ningpoensis, Asparagus cochinchinensis and Ophiopogon japonicas on contents of CYP450 and activities of CYP3A, CYP2E1 and CYP1A2 in rat].
Wu B; Liu P; Gao Y; Wang Y
Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(19):2710-4. PubMed ID: 22242435
[TBL] [Abstract][Full Text] [Related]
16. Effects of CYP inhibitors on precocene I metabolism and toxicity in rat liver slices.
Ly VT; Brock B
Chem Biol Interact; 2011 Sep; 193(2):109-18. PubMed ID: 21741958
[TBL] [Abstract][Full Text] [Related]
17. Metabolic oxidation and toxification of N-methylformamide catalyzed by the cytochrome P450 isoenzyme CYP2E1.
Hyland R; Gescher A; Thummel K; Schiller C; Jheeta P; Mynett K; Smith AW; Mráz J
Mol Pharmacol; 1992 Feb; 41(2):259-66. PubMed ID: 1538706
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of the chemoprotective agent diallyl sulfide to glutathione conjugates in rats.
Jin L; Baillie TA
Chem Res Toxicol; 1997 Mar; 10(3):318-27. PubMed ID: 9084912
[TBL] [Abstract][Full Text] [Related]
19. Oxidative metabolism of the anti-cancer agent mitoxantrone by horseradish, lacto-and lignin peroxidase.
Brück TB; Brück DW
Biochimie; 2011 Feb; 93(2):217-26. PubMed ID: 20887767
[TBL] [Abstract][Full Text] [Related]
20. The involvement of cytochrome P450 peroxidase in the metabolic bioactivation of cumene hydroperoxide by isolated rat hepatocytes.
Anari MR; Khan S; O'Brien PJ
Chem Res Toxicol; 1996 Sep; 9(6):924-31. PubMed ID: 8870978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
